-
Vetr Upgrades Alnylam On News Of Streamed Press Conference
Friday, December 9, 2016 - 5:08pm | 232Read More...On Friday, the Vetr crowd upgraded their rating for Alnylam Pharmaceuticals, Inc.(NASDAQ: ALNY) from its previous position at 1 star (Strong Sell) issued 88 days ago, to 4.5 star (Strong Buy). Crowd sentiment for the stock is edging positive with 66 percent of Vetr user ratings bullish. The...
-
Alnylam Pharmaceuticals Dips Lower After Company Announces 2016 Pipeline Goals Towards 'Alnylam 2020'
Monday, January 11, 2016 - 2:57pm | 171Read More...Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) were trading lower by nearly 7 percent at $78.74 mid-Monday afternoon after the company announced its pipeline goals for 2016 across its various segments. Alnylam Pharmaceuticals noted that by the end of 2020 it expects to achieve a profile...
